<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://isosolution-v2.staging.xiyx.ai/wp-sitemap.xsl" ?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"><url><loc>https://isosolution-v2.staging.xiyx.ai/news/wfnmb-2026-congress-cartagena-colombia/</loc><lastmod>2026-08-19T20:22:17+00:00</lastmod></url><url><loc>https://isosolution-v2.staging.xiyx.ai/news/health-canada-drug-master-file-dmf-submission/</loc><lastmod>2026-08-19T20:22:14+00:00</lastmod></url><url><loc>https://isosolution-v2.staging.xiyx.ai/news/snmmi-annual-meeting-exhibition/</loc><lastmod>2026-08-19T20:22:15+00:00</lastmod></url><url><loc>https://isosolution-v2.staging.xiyx.ai/news/european-association-of-nuclear-medicine/</loc><lastmod>2026-08-26T21:05:32+00:00</lastmod></url><url><loc>https://isosolution-v2.staging.xiyx.ai/news/the-canm-is-moving/</loc><lastmod>2021-03-09T09:18:50+00:00</lastmod></url><url><loc>https://isosolution-v2.staging.xiyx.ai/news/isosolutions-supports-lifetime-giving-to-langara-college-foundation/</loc><lastmod>2026-08-26T21:05:32+00:00</lastmod></url><url><loc>https://isosolution-v2.staging.xiyx.ai/news/https-isosolutions-com-wp-content-uploads-2021-07-psma-11-pet_ct-versus-choline-pet_ct-pdf/</loc><lastmod>2026-09-04T19:48:39+00:00</lastmod></url><url><loc>https://isosolution-v2.staging.xiyx.ai/news/https-www-canm-acmn-ca-page-1861897/</loc><lastmod>2021-07-19T09:14:57+00:00</lastmod></url><url><loc>https://isosolution-v2.staging.xiyx.ai/news/q-biomed-signs-distribution-agreement-with-isosolutions-for-the-sales-of-strontium89-in-canada/</loc><lastmod>2026-09-04T19:48:42+00:00</lastmod></url><url><loc>https://isosolution-v2.staging.xiyx.ai/news/snmmi-2022-annual-meeting/</loc><lastmod>2026-08-26T21:05:32+00:00</lastmod></url><url><loc>https://isosolution-v2.staging.xiyx.ai/news/welcome-to-isosolutions-roger-lafortune/</loc><lastmod>2021-09-29T08:30:07+00:00</lastmod></url><url><loc>https://isosolution-v2.staging.xiyx.ai/news/happy-holidays/</loc><lastmod>2021-12-23T16:51:01+00:00</lastmod></url><url><loc>https://isosolution-v2.staging.xiyx.ai/news/snmmi-2022-annual-meeting-june-11-14-2022-in-vancouver/</loc><lastmod>2022-02-03T09:16:02+00:00</lastmod></url><url><loc>https://isosolution-v2.staging.xiyx.ai/news/canm-annual-scientific-conference-2022/</loc><lastmod>2022-02-03T09:21:55+00:00</lastmod></url><url><loc>https://isosolution-v2.staging.xiyx.ai/news/chinese-new-year-2022/</loc><lastmod>2022-02-03T09:45:16+00:00</lastmod></url><url><loc>https://isosolution-v2.staging.xiyx.ai/news/welcome-to-isosolutions-john-odom/</loc><lastmod>2026-08-26T21:05:32+00:00</lastmod></url><url><loc>https://isosolution-v2.staging.xiyx.ai/news/snmmi-annual-meeting-2022/</loc><lastmod>2026-08-26T21:05:32+00:00</lastmod></url><url><loc>https://isosolution-v2.staging.xiyx.ai/news/uppi-annual-in-person-meeting/</loc><lastmod>2022-08-30T08:28:17+00:00</lastmod></url><url><loc>https://isosolution-v2.staging.xiyx.ai/news/the-35th-annual-congress-of-the-european-association-of-nuclear-medicine/</loc><lastmod>2022-08-30T09:43:11+00:00</lastmod></url><url><loc>https://isosolution-v2.staging.xiyx.ai/news/happy-new-year-lets-toast-to-yesterdays-achievements-and-tomorrows-bright-future/</loc><lastmod>2022-12-31T16:53:25+00:00</lastmod></url><url><loc>https://isosolution-v2.staging.xiyx.ai/news/chicago-snmmi-annual-meeting/</loc><lastmod>2026-08-26T21:05:32+00:00</lastmod></url><url><loc>https://isosolution-v2.staging.xiyx.ai/news/eanm-2023-vienna-from-9-to-13-september/</loc><lastmod>2023-09-01T14:15:44+00:00</lastmod></url><url><loc>https://isosolution-v2.staging.xiyx.ai/news/happy-new-lunar-year-2024/</loc><lastmod>2024-02-09T16:01:37+00:00</lastmod></url><url><loc>https://isosolution-v2.staging.xiyx.ai/news/isosolutions-is-excited-to-announce-our-recent-partnership-with-agilent/</loc><lastmod>2024-02-09T16:21:57+00:00</lastmod></url><url><loc>https://isosolution-v2.staging.xiyx.ai/news/7th-theranostic-world-congress/</loc><lastmod>2024-03-12T12:59:24+00:00</lastmod></url><url><loc>https://isosolution-v2.staging.xiyx.ai/news/molybdenum-mo-100/</loc><lastmod>2024-04-10T10:17:40+00:00</lastmod></url><url><loc>https://isosolution-v2.staging.xiyx.ai/news/the-eanm-annual-meeting/</loc><lastmod>2024-10-15T15:29:02+00:00</lastmod></url><url><loc>https://isosolution-v2.staging.xiyx.ai/news/happy-chinese-lunar-new-year-2025/</loc><lastmod>2025-01-28T10:29:45+00:00</lastmod></url><url><loc>https://isosolution-v2.staging.xiyx.ai/news/isosolutions-announces-new-managing-director-and-strategic-consultant/</loc><lastmod>2020-10-02T09:00:00+00:00</lastmod></url><url><loc>https://isosolution-v2.staging.xiyx.ai/news/building-a-resilient-canadian-isotope-supply-chain-critical-for-patients-around-the-world/</loc><lastmod>2020-06-03T09:00:00+00:00</lastmod></url><url><loc>https://isosolution-v2.staging.xiyx.ai/news/isosolutions-marketing-management-inc-and-cnic-partner-to-promote-nuclear-medicine-applications/</loc><lastmod>2020-02-11T09:00:00+00:00</lastmod></url><url><loc>https://isosolution-v2.staging.xiyx.ai/news/targeted-radionuclide-therapy/</loc><lastmod>2020-02-07T09:00:00+00:00</lastmod></url><url><loc>https://isosolution-v2.staging.xiyx.ai/news/two-world-leading-research-reactors-join-forces-to-create-dual-supply-of-medical-isotope-iodine-125/</loc><lastmod>2019-10-14T09:00:00+00:00</lastmod></url><url><loc>https://isosolution-v2.staging.xiyx.ai/news/isosolutions-welcomes-visitor-from-uganda-charity/</loc><lastmod>2019-07-17T09:00:00+00:00</lastmod></url><url><loc>https://isosolution-v2.staging.xiyx.ai/news/sales-and-marketing-manager-asia-appointed/</loc><lastmod>2019-04-25T09:00:00+00:00</lastmod></url><url><loc>https://isosolution-v2.staging.xiyx.ai/news/preclinical-efficacy-of-hk2-targeted-177luhu11b6-for-prostate-cancer-theranostics/</loc><lastmod>2019-04-22T09:00:00+00:00</lastmod></url><url><loc>https://isosolution-v2.staging.xiyx.ai/news/evaluation-of-111in-dota-5d3-a-surrogate-spect-imaging-agent-for-radioimmunotherapy-of-prostate-specific-membrane-antigen/</loc><lastmod>2019-03-25T09:00:00+00:00</lastmod></url><url><loc>https://isosolution-v2.staging.xiyx.ai/news/concomitant-177lu-dotatate-and-capecitabine-therapy-in-malignant-paragangliomas/</loc><lastmod>2019-02-25T09:00:00+00:00</lastmod></url><url><loc>https://isosolution-v2.staging.xiyx.ai/news/therapeutic-radiometals-worldwide-scientific-literature-trend-analysis-2008-2018/</loc><lastmod>2019-02-21T09:00:00+00:00</lastmod></url><url><loc>https://isosolution-v2.staging.xiyx.ai/news/new-strategic-commercial-alliance-between-isosolutions-and-fenix-medica/</loc><lastmod>2019-02-18T09:00:00+00:00</lastmod></url><url><loc>https://isosolution-v2.staging.xiyx.ai/news/bone-marrow-cell-homing-to-sites-of-acute-tibial-fracture-89zr-oxine-cell-labeling-with-positron-emission-tomographic-imaging-in-a-mouse-model/</loc><lastmod>2019-02-13T09:00:00+00:00</lastmod></url><url><loc>https://isosolution-v2.staging.xiyx.ai/news/chinese-lunar-new-year-year-of-the-pig/</loc><lastmod>2019-02-05T09:00:00+00:00</lastmod></url><url><loc>https://isosolution-v2.staging.xiyx.ai/news/reactors-back-online-expected-to-alleviate-shortage-of-mo-99/</loc><lastmod>2018-11-20T09:00:00+00:00</lastmod></url><url><loc>https://isosolution-v2.staging.xiyx.ai/news/safety-pharmacokinetics-and-dosimetry-of-a-long-acting-radiolabeled-somatostatin-analog-177lu-dota-eb-tate-in-patients-with-advanced-metastatic-neuroendocrine-tumors/</loc><lastmod>2018-11-05T09:00:00+00:00</lastmod></url><url><loc>https://isosolution-v2.staging.xiyx.ai/news/b-c-cancer-foundation-receives-anonymous-18-million-donation/</loc><lastmod>2018-10-29T09:00:00+00:00</lastmod></url><url><loc>https://isosolution-v2.staging.xiyx.ai/news/monosodium-glutamate-reduces-68ga-psma-11-uptake-in-salivary-glands-and-kidneys-in-preclinical-prostate-cancer-model/</loc><lastmod>2018-09-21T09:00:00+00:00</lastmod></url><url><loc>https://isosolution-v2.staging.xiyx.ai/news/first-in-human-study-of-177lu-eb-psma-617-in-patients-with-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2018-09-12T09:00:00+00:00</lastmod></url><url><loc>https://isosolution-v2.staging.xiyx.ai/news/single-low-dose-injection-of-evans-blue-modified-psma-617-radioligand-therapy-eliminates-prostate-specific-membrane-antigen-positive-tumors/</loc><lastmod>2018-09-06T09:00:00+00:00</lastmod></url><url><loc>https://isosolution-v2.staging.xiyx.ai/news/2018-chinese-society-of-nuclear-medicine-annual-meeting/</loc><lastmod>2018-08-02T09:00:00+00:00</lastmod></url></urlset>
